- $23.71bn
- $20.55bn
- $1.23bn
- 35
- 17
- 56
- 28
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 78.5 | 41.2 | 497 | 411 | 1,226 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 381 | 1,108 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 277 | 519 | 846 | 1,131 | 1,651 |
Operating Profit | -199 | -478 | -349 | -720 | -425 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -176 | -605 | -400 | -729 | -304 |
Provision for Income Taxes | |||||
Net Income After Taxes | -181 | -608 | -408 | -710 | -295 |
Net Income Before Extraordinary Items | |||||
Net Income | -181 | -608 | -408 | -710 | -295 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -181 | -608 | -408 | -710 | -295 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.69 | -13.4 | -7.99 | -13 | -5.16 |
Dividends per Share |